Understanding exactly how the brain generates placebo analgesia has long been one of pain medicine's most consequential puzzles. If clinicians can identify which neural mechanisms underlie expectation-driven pain relief, they may be able to deliberately engineer more effective pain management strategies — potentially reducing opioid dependence and improving outcomes in chronic pain populations.

This systematic meta-analysis pooled individual participant data from 16 within-participant neuroimaging studies, encompassing 409 participants, to disentangle two foundational routes to placebo analgesia: verbal suggestion alone versus verbal suggestion paired with classical conditioning. Both approaches activated the dorsolateral prefrontal cortex and inferior parietal cortex during pain processing while suppressing activity in the insula, putamen, and primary sensory cortices — a shared neural signature suggesting a common top-down inhibitory pathway. However, conditioning specifically amplified engagement of context-representation regions including the dorsomedial and dorsolateral prefrontal cortices and produced greater suppression of nociceptive circuits. Crucially, the combined approach — conditioning plus instruction — generated stronger analgesia than either alone, and this enhancement was statistically mediated by increased ventromedial prefrontal cortex and dorsal caudate activation, paired with reduced sensory-nociceptive and cerebellar activity. The Neurologic Pain Signature, a validated multivariate brain marker, showed a stronger inverse relationship with analgesia in the conditioned condition, lending mechanistic specificity to the results.

This work is notable for its methodological rigor: individual-participant-level meta-analysis is substantially more powerful than aggregated study-level approaches, and the within-participant design controls for considerable individual variability. Contextually, this finding extends prior work by Wager and colleagues on descending pain modulation and aligns with predictive coding frameworks in which conditioning more robustly updates prior pain predictions than verbal instruction alone. A key limitation is that all studies involve healthy adults in experimental pain settings, so translation to clinical chronic pain — where central sensitization and psychological comorbidities dominate — remains unproven. Still, the identification of the ventromedial prefrontal-caudate axis as the conditioning-specific mediator represents a potentially actionable target for neurostimulation or behavioral therapeutic protocols.